A diary of the thought process behind my investment decisions
Celgene On The Right Path
In my article a few weeks back I noted that the only thing missing from Celgene's stock was a share buyback. A few days ago management announced a $1 billion repurchase plan, which amounts to about 4% of Celgene's outstanding stock. I would now be a buyer on a pullback for more than just a trade.